Bloomberg Law
Sept. 30, 2020, 6:01 PM

Reams of Useless Covid Data Drive Reckoning on Clinical Trials

Jeannie Baumann
Jeannie Baumann

The coronavirus vaccine race proves researchers need to step off campus more to meet patients in doctors’ offices and health clinics to improve clinical trials, something the FDA’s drug chief said requires “very serious soul searching.”

“Right now the situation for clinical trials with this disease is like starvation in the midst of plenty,” Janet Woodcock said at a Friends of Cancer Research leadership reception.

The rush to find a vaccine has left the Food and Drug Administration swimming in useless data. One agency analysis found just 6% of all clinical trials are yielding results the agency deems actionable, ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.